Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.770
-0.060 (-2.12%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Nkarta Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
108
Market Cap
197.47M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MacroGenics | 149.50M |
| Karyopharm Therapeutics | 146.07M |
| OmniAb | 18.67M |
| MediWound | 16.96M |
| Caribou Biosciences | 11.16M |
NKTX News
- 13 days ago - Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers - GlobeNewsWire
- 13 days ago - Nkarta Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 19 days ago - Nkarta to Participate in Needham Virtual Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 7 weeks ago - Nkarta Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Nkarta Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Nkarta to Participate in March Investor Conferences - GlobeNewsWire
- 5 months ago - Nkarta Transcript: Evercore ISI 8th Annual HealthCONx Conference - Transcripts